Tai Yu, Sun Yi-Ming, Zou Xue, Pan Qiong, Lan Ya-Dong, Huo Qiang, Zhu Jing-Wen, Guo Fei, Zheng Chang-Quan, Wu Cheng-Zhu, Liu Hao
Department of Pharmacy, Bengbu Medical College, Bengbu, Anhui 233030, P.R. China.
Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Exp Ther Med. 2016 Oct;12(4):2681-2687. doi: 10.3892/etm.2016.3630. Epub 2016 Aug 30.
Traditional Chinese medicine (TCM) is important in the provision of anti-tumor drugs. Recently, studies have shown that certain types of TCM agents are able to control the growth of tumors, enhance the body's immune function and enhance the therapeutic effect of chemotherapeutic drugs. In women, breast carcinoma is the most common tumor type and the second most common cause of death from cancer. () is commonly used in TCM. The aim of the present study was to investigate the effects of extract on the proliferation and apoptosis of MDA-MB-231 breast cancer cells. Cell proliferation was assessed using MTT and colony formation assays. In addition, propidium iodide (PI)/Annexin V-FITC staining was used to investigate the apoptosis of MDA-MB-231 cells following treatment with extract. The protein expression levels of B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) were also detected using western blot analysis, while a JC-1 staining assay was used to assess the mitochondrial membrane potential (ΔΨm). The results of the MTT assay showed that the proliferation and colony formation of MDA-MB-231 cells were inhibited following treatment with the extract. Furthermore, the PI/Annexin-V staining showed that the apoptosis of MDA-MB-231 cells was enhanced by the extract, in a concentration-dependent manner. The extract also lowered the ΔΨm of MDA-MB-231 cells, upregulated the expression of Bax and inhibited the expression of Bcl-2. In conclusion, these results showed that the extract inhibited the proliferation and induced apoptosis of breast cancer MDA-MB-231 cells.
传统中药在抗肿瘤药物的提供方面具有重要意义。最近,研究表明某些类型的中药制剂能够控制肿瘤生长、增强机体免疫功能并提高化疗药物的治疗效果。在女性中,乳腺癌是最常见的肿瘤类型,也是癌症死亡的第二大常见原因。()是中药中常用的。本研究的目的是探讨提取物对MDA-MB-231乳腺癌细胞增殖和凋亡的影响。使用MTT和集落形成试验评估细胞增殖。此外,碘化丙啶(PI)/膜联蛋白V-异硫氰酸荧光素(FITC)染色用于研究提取物处理后MDA-MB-231细胞的凋亡情况。还使用蛋白质印迹分析检测B细胞淋巴瘤-2(Bcl-2)和Bcl-2相关X蛋白(Bax)的蛋白表达水平,同时使用JC-1染色试验评估线粒体膜电位(ΔΨm)。MTT试验结果表明,提取物处理后MDA-MB-231细胞的增殖和集落形成受到抑制。此外,PI/膜联蛋白-V染色表明提取物以浓度依赖的方式增强了MDA-MB-231细胞的凋亡。提取物还降低了MDA-MB-231细胞的ΔΨm,上调了Bax的表达并抑制了Bcl-2的表达。总之,这些结果表明提取物抑制了乳腺癌MDA-MB-231细胞的增殖并诱导其凋亡。